Insect neuropeptides represent more than 90% of all insect hormones. The pheromone biosynthesis activating neuropeptide (PBAN)/pyrokinin family is a major group of insect neuropeptides. These neuropeptides regulate a variety of biological functions from embryo to adult in moths including, sex pheromone biosynthesis and diapause. Other functions are yet to be determined. The identification of suitable target genes is most important for the successful application of RNA interference (RNAi) for pest insect control. Insect neuropeptide genes including PBAN are known to have multiple functions and could be a good target for RNAi suppression. In this study, we selected the PBAN gene and its neuropeptide products as an RNAi target for two economically important moth species, the corn earworm, Helicoverpa zea (Boddie), and the tobacco budworm, Heliothis virescens (Fabricius). We investigated RNAi effects on immature moths that had ingested the specific double-stranded RNA (dsRNA) starting at the first instar larva through pupation. We report that RNAi treatments resulted in delay of larval growth, interference of pupal development, and mortality in the two pest moths. In addition, we selected small interfering RNAs (siRNAs) to determine if they have negative phenotypic effects similar to their full-length RNAi parents. This is one of the few examples of negative RNAi effects on lepidopteran pests via feeding and suggests possible RNAi-based control of pest moths.
RNA interference (RNAi) is a post-transcriptional gene-silencing mechanism using double-stranded RNA (dsRNA) (Fire et al. 1998) , that provides a new avenue for insect pest management. A decade ago two breakthrough reports demonstrated that insects feeding on plants-medicated with a specific RNAi resulted in significant suppression of the target gene and a phenotypic effect, e.g., increased mortality of the cotton bollworm, Helicoverpa armigera (Mao et al. 2007) and the western corn rootworm, Diabrotica virgifera (Baum et al. 2007) . Although there are many technical hurdles to overcome, including target gene selection and RNAi delivery (Asokan 2008 , Huvenne and Smagghe 2010 , Terenius et al. 2011 , Scott et al. 2013 , costeffective applications could be possible near US$4 per gram dsRNA (Andrade and Hunter 2016, Ghosh et al. 2018 ). In addition, RNAibased insect pest control has made significant progress in many insect groups (Zotti and Smagghe 2015, Gundersen-Rindal et al. 2017) .
In Lepidoptera, the effects of RNAi have been investigated in over 20 species from 10 families using various delivery tools (Terenius et al. 2011 , Xu et al. 2016 . Although those studies were focused mainly on determination of the biological functions of target genes, the RNAi technology looks very promising for development of lepidopteran pest control methods too. Gene-silencing levels by RNAi vary depending on target genes and pests, so the identification of a suitable target gene and/or physiological system is critical. A feasible approach for RNAi target gene screening is to search targets or systems previously observed from the same or similar insect groups. Another cost-effective approach is to search for RNAi targets from known functional gene analyses and previous RNA mechanism studies from model insects to increase the likelihood of success in initial target screening (Zhang et al. 2013) . Therefore, the screening strategy to identify an appropriate RNAi target genes(s) is a key initial step.
Insect neuropeptides are the largest group of insect hormones. A variety of peptide families have been identified from insects, that offer potential for pest control by disrupting specific physiological systems (Gade and Goldsworthy 2003) . One of these families is the pheromone biosynthesis activating neuropeptide (PBAN)/pyrokinin family defined by a conserved C-terminal pentapeptide (e.g., FXPRLamide) that is the core signature needed for biological activity (Kuniyoshi et al. 1992 , Raina and Kempe 1992 , Rafaeli 2009 ). During the past three decades PBAN/pyrokinin peptides have been identified and characterized from many insects and other arthropods.
Studies have demonstrated a variety of biological functions, including stimulation of sex pheromone biosynthesis in Helicoverpa zea (Boddie) (Raina et al. 1989 ), induction of melanization in Bombyx mori (Linnaeus) (Lepidoptera: Bombycidae) (Matsumoto et al. 1990 ), induction of embryonic diapause in B. mori (Suwan et al. 1994 , Uehara et al. 2011 , termination of development of pupal diapause in Heliothis virescens (Fabricius) (Xu and Denlinger 2003) in moths, stimulation of visceral muscle contraction in Periplaneta americana (Linnaeus) (Blattodea: Blattidae) (Predel and Nachman 2001) , and acceleration of puparium formation in Sarcophaga bullata (Parker) (Zdarek et al. 1997) . Therefore, genes for PBAN/ pyrokinin family peptides are involved in multiple physiological functions, making it a good RNAi target, which has previously been shown to suppress transcripts of PBAN genes in lepidotperans , Lu et al. 2015 , Du et al. 2017 .
Helicoverpa and Heliothis moths are major lepidopteran pests of many economically important crops including corn, cotton, soybean, green and hot peppers, tomatoes, and potatoes throughout the world (Cunningham and Zalucki 2014) . Research on these moths has documented their basic physiology, chemical ecology, and integrated pest management (IPM) (Cunningham and Zalucki 2014) . Currently, major control tools for these species rely on chemical insecticides and/or transgenic Bt, but these methods are continuously encountering insecticide resistance and nontarget toxicity.
Previously, we selected the PBAN gene as an RNAi target for the corn earworm (CEW), H. zea, and investigated both genotypic and phenotypic impacts of PBAN dsRNA injected into pupae . These results demonstrated the negative effects of PBAN RNAi on the PBAN gene transcript and on the pupae and resulting adults. In the current study, we use two sibling species, the CEW, H. zea, and tobacco budworm (TBW), H. virescens to determine the impact of PBAN dsRNA treatments fed from the first instar larva until pupation. We demonstrate delayed larval growth, incomplete pupal development, and mortality in these two pest moths species. The multifunctional roles demonstrated for the FXPRL peptides translated from the PBAN mRNA illustrate the potential of this RNAi target gene as an RNAi-based control method.
Materials and Methods

Moths
Moth eggs for the CEW and the TBW were purchased from Bio-Serv (Frenchtown, NJ) and maintained at 25 ± 2°C under 15:9 (L:D) h photoperiod until they hatched as larvae. The larvae were reared at 25 ± 1°C and 60 ± 5% relative humidity under the same photoperiod. The experiment was conducted with one generation of the moths in this study.
Cloning the PBAN Genes and Constructing the dsRNAs
The whole brain of 1-to 3-day old H. zea, and H. virescens adults were dissected to isolate mRNA for synthesis of cDNA using Invitrogen MicroFast mRNA purification kit and GeneRacer cDNA synthesis kit (Invitrogen, Waltham, MA). Sense and anti-sense primer sets (Table 1) 
PBAN dsRNA Feeding to Moth Larvae
Three concentrations of dsRNA were prepared for larval feeding experiments (μg dsRNA/g larval diet): 1) 0.1 μg/g, 2) 1 μg/g, and 3) 10 μg/g. The dsRNA constructs were 1) Hez-PBAN RNAi, 2) Hez-PBAN small interfering RNA (siRNA) for the CEW, and 3) Hev-PBAN RNAi for the TBW. Artificial diet powders for the two species were purchased from Bio-Serv, and mixed in water and boiled as described in the manufacturer's protocol. The dsRNA treatments or GFP dsRNA control were added and mixed into the fresh diet after it had cooled to 65°C or below, but before the diet solidified. The diets were sealed in a plastic bag, and frozen until used. One half of the calculated amount of diet (~6 cm 3 ) needed to pupal development was placed in individual cups (30 ml), then newly hatched first instar larvae were transferred to the diet (one per cup). GFP dsRNA or water were used as negative controls. Each treatment was composed of 25 larvae. The moth larval weight and mortality were recorded daily. Midway in the expected larval development period (about 21 d), the larvae were transferred to a new cup containing a 
Statistical Analysis
Statistical procedures, e.g., Kaplan-Meier Survival or t-tests, and graphical representations were carried out using GraphPad Prism, version 6 (GraphPad Software Inc., San Diego, CA). See specific experimental section for details. In some situations, statistical significance was determined by inspection, as indicated in the results section.
Results
Impact of Feeding PBAN dsRNA to H. zea and H. virescens CEW larval mortality for the CEW PBAN-10 treatment (10 μg/g diet; 0.001%) was significantly greater than the CEW Control ( Fig. 1) : Logrank test: χ 2 = 11.27, df = 1, P = 0.0008. Since this concentration most closely followed the control, the other two concentrations of PBAN dsRNA (1.0 and 0.1 μg/g) are also significantly greater than the control (P = 0.0011 and P = 0.0015, respectively). Comparison of the two concentrations with the most divergent (1 and 10 μg/g diet) mortality showed no significant difference: Logrank test: χ 2 = 0.0537, df = 1, P = 0.8167; therefore, results for the three treatment concentrations are not significantly different from each other.
CEW PBAN-0.1 (0.1 μg/g diet) and dsGFP-0.1 were the lowest concentrations evaluated (Fig. 2) . Mortality for the CEW PBAN-0.1 treatment was significantly greater than the CEW Control and the dsGFP control (Logrank test: χ 2 = 11.27, df = 1, P = 0.0008; and χ 2 = 4.535, df = 1, P = 0.0332, respectively). The GFP and CEW Controls were not significantly different: Logrank test: χ 2 = 2.235, df = 1, P = 0.1350. The results indicate all concentrations of the CEW PBAN dsRNA resulted in increased larval mortality.
The effects Hev-PBAN dsRNA on TBW were evaluated using the same doses and procedure described for the CEW treatments. TBW larval weight and mortality was monitored for ~21 d until pupation (Fig. 3) . The larval mortality for the TBW PBAN-1 was significantly different compared to the TBW control: Logrank test: χ 2 = 6.208, df = 1, P = 0.0127; therefore, the TBW PBAN-10 concentration was also significantly different from the control (P = 0.0003).
The TBW PBAN 0.1 treatment, shown in Figs. 3 and 4 was not significantly different from the control (Logrank test: χ 2 = 3.575, df = 1, P = 0.0587). The corresponding dsGFP-0.1 control was not significantly different from the untreated control diet (dsGFP-0.1 vs. Control: Logrank test: χ 2 = 2.167, df = 1, P = 0.1410; Fig. 4 ).
Phenotypic Impacts of siRNA on H. zea
Four siRNAs (25 nucleotides) were designed from four different sites of H. zea mRNA sequences (585 nucleotides) and synthesized respectively ( Fig. 5A and B ). Each siRNA (10 μg per pupa) was injected into two pupae age groups, 1-to 2-day-old and 4-to 5-dayold. No phenotypic effect was observed from the 1-to 2-day-old group (data not shown). However, for the 4-to 5-day-old pupae group, the siRNA507 treatment showed 50% pupal mortality due to failure of pupation or adult emergence (Fig. 5C ). The results from other siRNAs were similar to controls, GFP or saline treatment. Due to insufficient amount of the siRNA205 we were not able to evaluate this siRNA construct against 4-to 5-day-old pupae.
We selected the siRNA507 for further evaluation at three concentrations, 0.1, 1.0, and 10.0 μg/g standard diet (Fig. 6) . The mortality patterns for CEW-507-10 and CEW-507-1 were similar and significantly greater than the CEW-Control: Logrank test: χ 2 = 7.019, df = 1, P = 0.0081; χ 2 = 5.569, df = 1, P = 0.0174, respectively. Fig. 1 . The mortality of CEW larvae from first instar to just prior to pupation after treatment of three concentrations of PBAN dsRNAs. The CEW Control was fed the standard CEW diet only. PBAN-0.1, 1, and 10 refer to the concentration evaluated dsRNA/diet (µg/g). Mortality curves were compared using the standard Kaplan-Meier survival analysis. The asterisk (*) indicates significant differences by Logrank test (PBAN-0.1, P = 0.0015; PBAN-1.0, P = 0.0011; PBAN-10, P = 0.0008) from the control. Each treatment was composed of 25 larvae. Fig. 2 . The mortality of corn ear worm (CEW) larvae from the first instar to just prior to pupation after treatment of PBAN dsRNA (CEW PBAN) or GFP dsRNA (dsGFP). The CEW Control was fed the standard CEW diet only. Mortality curves were compared using the standard Kaplan-Meier survival analysis. The asterisk (*) indicates significant difference by Logrank test from the CEW Control (P = 0.0008) and the GFP control (P = 0.0332). The dsGFP and CEW Controls were not significantly different (P = 0.1350). Each treatment was composed of 25 larvae.
In addition, results for CEW-507-10 were not significantly different from CEW PBAN-0.1 results: Logrank test, χ 2 = 0.6441, df = 1, P = 0.4222 and CEW507-1 results were not significantly different from CEW PBAN-0.1 results. Mortality for the CEW-507-0.1 was not significantly different from the CEW Control, nor different from the CEW-507-10: Logrank test: χ 2 = 0.9862, df = 1, P = 0.3207; and χ 2 = 0.6441, df = 1, P = 0.4222, respectively.
Discussion
Our previous study injected the PBAN dsRNA into pupae of H. zea, which resulted in delayed pupal development, increased mortality, decreased the PBAN mRNA expression, and reduced sex pheromone production in those female adults that eclosed . While injection of the dsRNA directly into the target insect hemocoel is likely the most efficient dsRNA delivery method to investigate phenotypic effects, it is not practical for the development of an RNAi-based control method. Oral administration of dsRNA (ingestion) would be more feasible; however, the target dsRNA must survive in the midgut and pass into the hemolymph where it can then act on the target gene. This study continued to evaluate the impact of PBAN RNAi on two pest moths, the CEW, H. zea, and TBW, H. virescens, when larvae ingested specific dsRNA constructs. Our results showed significant phenotypic impacts including larval mortality for CEW and TBW, which is a major step forward in the application of this technology to control pest moths.
The phenotypic effects of PBAN RNAi on H. zea and H. virescens were mainly expressed in larval mortality and failure of larva 6 . The mortality of corn ear worm (CEW) larvae from first instar to just prior to pupation after treatment of PBAN dsRNAs. The CEW Control was fed standard CEW diet only. The asterisk (*) indicates the larval mortalities for PBAN-0.1, CEW-507-10, and CEW-507-1 were significantly greater than the CEW-Control by Logrank test: P = 0.0015, P = 0.0081, and P = 0.0174, respectively). The two mortality profiles were not significantly different from CEW PBAN-0.1 (P = 0.4222). The mortality of CEW-507-0.1 was not significantly different from the CEW Control (P = 0.3207), or from CEW-507-10 (P = 0.4222). Each treatment was composed of 25 larvae to undergo pupal development. The PBAN RNAi impacts observed for the two species were slightly different ( Fig. 7) . Larval mortality of H. zea gradually increased to a maximum in the late larval stage, 14to 15-day-old, when the larvae are normally preparing to pupate. However, for H. virescens larvae, mortality was low until day 10, after which, it significantly increased. The highest mortality in both moth species occurred during the pupal stage, where pupae failed to eclose adults, or if they did emerge to adults they were deformed with their wings and appendages unable to expand, resulting in death. The same phenotypic effect was observed from H. zea pupae after PBAN dsRNA injection . Moth diapause hormone (DH) peptides are also encoded from the same PBAN mRNA (Sato et al. 1993) and have been demonstrated to be involved in normal pupa to adult development in a moth (Xu and Denlinger 2003) ; therefore, interference of pupal/adult development in this report may be due to a decrease in DH production. Experiments remain to be carried out on the quantification of peptide levels, with and without PBAN RNAi treatments.
Moth PBAN genes encode multiple neuropeptides including PBAN, DH and three additional peptides (Choi et al. 1998 ). RNAi knockdown of PBAN genes in moths significantly reduced the production of sex pheromones in H. zea , Spodoptera litura (Lu et al. 2015) , and the biosynthesis of fatty acyl alcohols in H. armigera males (Du et al. 2017 ). RNAi for PBAN receptor genes also led to a significant decrease in the biosynthesis of male components in H. armigera (Bober and Rafaeli 2010) , the sex pheromones in Plutella xylostella (Lee et al. 2011) , and the trail pheromone in Solenopsis invicta .
Although RNAi represents a new direction for insect pest management, technical challenges for practical RNAi application in the field must be overcome (Huvenne and Smagghe 2010 , Terenius et al. 2011 , Burand and Hunter 2013 , Scott et al. 2013 , Gundersen-Rindal et al. 2017 . The key factor is to identify a suitable target gene and/or physiological system with a high level of gene silencing, followed by insect developmental arrestment and/or death (Zhang et al. 2013) . Insect neuropeptide hormones are involved in many important functions, such as regulation of fat body homeostasis, feeding, digestion, excretion, circulation, reproduction, metamorphosis, and behavior (Gade and Goldsworthy 2003, Clark et al. 2004) . Many insect neuropeptides identified to date have been found to be involved in multiple biological functions, after they were first determined to have singular functions. The PBAN/pyrokinin (or PBAN/DH) gene is one of the best examples of a single gene that produces multiple peptides to stimulate multiple physiological functions. Insect neuropeptides and their receptors have been suggested to be good targets and potential candidates for biologically-based insecticide discovery, including their suppression using RNAi (Altstein and Nassel 2010 , Van Hiel et al. 2010 , Audsley and Down 2015 . The work presented here demonstrates that in two pest moths, PBAN dsRNA can survive gut enzymes and exert lethal effects after ingestion. Thus, supporting use of RNAi of this specific neuropeptide for pest insect control, and opening the door to experimentation with other members of the large neuropeptide family.
